<html>
<head>PUBMED IDs for CXCL4L1</head>
<body bgcolor='#C5F0F2'><h1>CXCL4L1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/15459074/'>Platelets release CXCL4L1, a nonallelic variant of the chemokine platelet factor-4/CXCL4 and potent inhibitor of angiogenesis.</a> October 2  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/17218382/'>PF-4/CXCL4 and CXCL4L1 exhibit distinct subcellular localization and a differentially regulated mechanism of secretion.</a> January 16  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17575164/'>Platelet factor-4 variant chemokine CXCL4L1 inhibits melanoma and lung carcinoma growth and metastasis by preventing angiogenesis.</a> June 19  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/22338571/'>Platelet-derived chemokines in atherogenesis: what's new?</a> January 8  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22384011/'>PF-4var/CXCL4L1 predicts outcome in stable coronary artery disease patients with preserved left ventricular function.</a> August 28  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22555803/'>Impaired CXCL4 expression in tumor-associated macrophages (TAMs) of ovarian cancers arising in endometriosis.</a> May 23  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/25373734/'>Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47-70) and CXCL4L1(47-70) in an EGF-dependent breast cancer model.</a> September 1  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/28042949/'>Recombinant Parvoviruses Armed to Deliver CXCL4L1 and CXCL10 Are Impaired in Their Antiangiogenic and Antitumoral Effects in a Kaposi Sarcoma Tumor Model Due To the Chemokines' Interference with the Virus Cycle.</a> January 3  2017<br></body></html>
